Stock Events

Stock Events

Harvard Bioscience 

$7.48
38
-$0.07-0.93% Friday 20:00
-$0.42-5.61%Friday 23:30After hours

Statistics

Day High
7.44
Day Low
7.44
52W High
9.4
52W Low
3.8
Volume
213
Avg. Volume
-
Mkt Cap
34.05M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

10NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.62
-0.39
-0.17
0.06
Expected EPS
-0.17
Actual EPS
N/A

Financials

-65.51%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
86.55MRevenue
-56.7MNet Income

Analyst Ratings

7.50Average Price Target
The highest estimate is 7.50.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
0%
Hold
100%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow HBIO. It's not an investment recommendation.
Microsoft
8
MSFT
Apple
7
AAPL
Amazon
7
AMZN
Alphabet
7
GOOGL

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Thermo Fisher Scientific
TMO
Mkt Cap217.52B
Thermo Fisher Scientific offers a broad range of products for the life sciences industry, overlapping with Harvard Bioscience's offerings in laboratory equipment and consumables.
Danaher
DHR
Mkt Cap142.32B
Danaher Corporation operates in similar segments as Harvard Bioscience, including life sciences and diagnostics, making them direct competitors in several markets.
Bio-Rad Laboratories
BIO
Mkt Cap9.53B
Bio-Rad Laboratories provides instruments and consumables in the life science research and clinical diagnostics markets, competing directly with Harvard Bioscience's product lines.
Agilent Technologies
A
Mkt Cap41.95B
Agilent Technologies offers products and services for the life sciences, diagnostics, and applied chemical markets, making it a competitor in areas overlapping with Harvard Bioscience's focus.
Waters
WAT
Mkt Cap40.49B
Waters Corporation specializes in analytical instruments for the life sciences sector, directly competing with Harvard Bioscience in the laboratory equipment market.
Bruker
BRKR
Mkt Cap8.79B
Bruker Corporation offers scientific instruments and analytical and diagnostic solutions, competing with Harvard Bioscience in the life science research tools sector.
Bio-Rad Laboratories
BIO.B
Mkt Cap8.84B
Bio-Rad Laboratories, through its Class B shares, represents another avenue of competition in the life sciences and diagnostics markets, directly challenging Harvard Bioscience's offerings.
Mettler-Toledo International
MTD
Mkt Cap28.43B
Mettler-Toledo International offers precision instruments and services for professional use, competing with Harvard Bioscience in the laboratory equipment and analytical instruments sector.
Repligen
RGEN
Mkt Cap9.42B
Repligen Corporation provides bioprocessing technologies and solutions, which competes with Harvard Bioscience's offerings in the life sciences research and clinical diagnostics fields.

About

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.
Show more...
CEO
John D. Duke
Employees
339
Country
United States
ISIN
US4169062043
WKN
000A423J5

Listings

STU
DE
HBI0.STU
MU
DE
HBI0.MU
XNAS
US
HBIO
BOATS
BOATS
HBIO.BOATS

0 Comments

Share your thoughts

FAQ

What is Harvard Bioscience stock price today?▼
The current price of HBIO is $7.48 USD — it has decreased by -0.93% in the past 24 hours. Watch Harvard Bioscience stock price performance more closely on the chart.
What is Harvard Bioscience stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Harvard Bioscience stocks are traded under the ticker HBIO.
Is Harvard Bioscience stock price growing?▼
HBIO stock has risen by +12.4% compared to the previous week, the month change is a +20.84% rise, over the last year Harvard Bioscience has showed a +52.65% increase.
What is Harvard Bioscience market cap?▼
Today Harvard Bioscience has the market capitalization of 34.05M
When is the next Harvard Bioscience earnings date?▼
Harvard Bioscience is going to release the next earnings report on November 10, 2026.
What were Harvard Bioscience earnings last quarter?▼
HBIO earnings for the last quarter are -0.14 USD per share, whereas the estimation was -0.21 USD resulting in a +33.33% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Harvard Bioscience revenue for the last year?▼
Harvard Bioscience revenue for the last year amounts to 86.55M USD.
What is Harvard Bioscience net income for the last year?▼
HBIO net income for the last year is -56.7M USD.
How many employees does Harvard Bioscience have?▼
As of August 23, 2026, the company has 339 employees.
In which sector is Harvard Bioscience located?▼
Harvard Bioscience operates in the Health & Wellness sector.
When did Harvard Bioscience complete a stock split?▼
The last stock split for Harvard Bioscience was on March 16, 2026 with a ratio of 1:10.
Where is Harvard Bioscience headquartered?▼
Harvard Bioscience is headquartered in HOLLISTON, United States.